Healthcare Industry News: ventilator
News Release - December 10, 2007
HemCon Medical Technologies Given Exclusive Rights to Distribute Life-Saving DeviceSAVe Technology Enhances Front-Line Battlefield Care
PORTLAND, Ore.--(HSMN NewsFeed)--HemCon Medical Technologies Inc., a leading provider of hemostatic bandages and military health care products, today announced its exclusive rights to market and distribute the Simplified Automated ventilator (SAVe) by AutoMedx in the United States. This high-tech medical device will be used by military personnel to supply critical resuscitation care to injured soldiers on the battlefield.
Now approved by the FDA for use, the SAVe was on display in August at DARPATech, the annual conference for the Defense Advanced Research Projects Agency, which is the central research and development organization for the Department of Defense. This easy-to-use, battery-powered, portable, hands-free ventilator will help combat medics provide breathing assistance to far-forward soldiers injured in battle.
The SAVe incorporates a number of unique features to provide uncompromised ventilatory support in a compact design. Created for use on the battlefield, the unit utilizes a battery-driven pump to deliver life-saving air for more than five hours on a single charge. Using ambient air, the device does not require a compressed gas source, and at 3.1 pounds, the SAVe is lightweight enough for easy deployment to the battlefield. Most importantly, the device’s hands-free operation allows medics to attend to other injuries or further assist in an evacuation situation.
Additionally, multiple safety and integrated alarm features ensure patient safety when the SAVe is in use. Alarms warn of blockage, disconnect, low battery and temperature-related issues. These alarms are uniquely positioned on the device and can be discerned in a low-light, high-noise environment. The audible and visual alarms can be suppressed individually or together, depending on the soldier’s need to avoid detection.
“The SAVe device gives medics an indiscriminate health care option in situations when being detected can mean the difference between life and death,” said John W. Morgan, HemCon president and CEO. “We’re honored AutoMedx has selected HemCon as the distributor of choice for a device that will help significantly decrease lives lost in battle.”
The SAVe is designed by AutoMedx and received FDA approval Sept. 6, 2007. HemCon also plans to distribute the SAVe in foreign markets under a non-exclusive agreement.
HemCon is currently accepting orders for the SAVe. Initial ship dates are expected in Jan. 2007.
About HemCon Medical Technologies Inc.
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures and markets innovative technologies to control bleeding and infection resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital, dental and clinical settings where rapid control of bleeding is of critical importance. The HemCon® Bandage was developed in collaboration with the Oregon Medical Laser Center and Providence St. Vincent’s Hospital. HemCon’s manufacturing and corporate headquarters are located in Portland, Ore. For more information, please visit www.hemcon.com.
About AutoMedx Inc.
Founded in 2004, AutoMedx is focused on the design and manufacture of improved mechanical ventilation devices. AutoMedx is a member of the BioSTAR Group, an affiliation of several R&D and consulting companies. AutoMedx is located in Germantown, MD.
Source: HemCon Medical Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.